These observations underscore a shift in neuro-oncology: while GBM exemplifies the pitfalls of target selection without functional validation, NF2-mutant meningiomas demonstrate how a well-defined molecular context can expose actionable dependencies (47, 55). This evidence concerns the gene NF2 and meningioma.